Skip to main content
Top
Published in: Infection 3/2016

01-06-2016 | Brief Report

High proportion of HIV late presenters at an academic tertiary care center in northern Germany confirms the results of several cohorts in Germany: time to put better HIV screening efforts on the national agenda?

Authors: Guido Schäfer, Benno Kreuels, Stefan Schmiedel, Sandra Hertling, Anja Hüfner, Olaf Degen, Jan van Lunzen, Julian Schulze zur Wiesch

Published in: Infection | Issue 3/2016

Login to get access

Abstract

165 treatment-naive patients who first presented at the infectious disease clinic of the University Medical Center Hamburg-Eppendorf from 2009 to 2011 were retrospectively analyzed with emphasis on patients with late presentation (LP). In line with other recent German reports, there was a large proportion of 105 of the 165 treatment-naïve patients (63.6 %) who presented late. Old age, heterosexual transmission risk and migrant background were associated risk factors for late presentation. Thus, further intensified national efforts like the HIV in Europe initiative are needed to identify such patients at high risk for HIV infection.
Literature
1.
go back to reference Kittner JM, von Bialy L, Wiltink J, Thomaidis T, Gospodinov B, Rieke A, Katz F, Discher T, Rath K, Claus B, Held G, Friese G, Schappert B, Schuchmann M, Galle PR. Lack of awareness in both patients and physicians contributes to a high rate of late presentation in a South West German HIV patient cohort. Infection. 2015;43(3):299–305.CrossRefPubMed Kittner JM, von Bialy L, Wiltink J, Thomaidis T, Gospodinov B, Rieke A, Katz F, Discher T, Rath K, Claus B, Held G, Friese G, Schappert B, Schuchmann M, Galle PR. Lack of awareness in both patients and physicians contributes to a high rate of late presentation in a South West German HIV patient cohort. Infection. 2015;43(3):299–305.CrossRefPubMed
2.
go back to reference Platten M, Linnemann R, Kummerle T, Jung N, Wyen C, Ehren K, Gravemann S, Gillor D, Cornely OA, Fischer J, Lehmann C, Rockstroh JK, Fatkenheuer G, Vehreschild JJ. Clinical course and quality of care in ART-naive patients newly presenting in a HIV outpatient clinic. Infection. 2014;42(5):849–57.CrossRefPubMed Platten M, Linnemann R, Kummerle T, Jung N, Wyen C, Ehren K, Gravemann S, Gillor D, Cornely OA, Fischer J, Lehmann C, Rockstroh JK, Fatkenheuer G, Vehreschild JJ. Clinical course and quality of care in ART-naive patients newly presenting in a HIV outpatient clinic. Infection. 2014;42(5):849–57.CrossRefPubMed
3.
go back to reference Spornraft-Ragaller P, Boashie U, Stephan V, Schmitt J. Analysis of risk factors for late presentation in a cohort of HIV-infected patients in Dresden: positive serology for syphilis in MSM is a determinant for earlier HIV diagnosis. Infection. 2013;41(6):1145–55.CrossRefPubMed Spornraft-Ragaller P, Boashie U, Stephan V, Schmitt J. Analysis of risk factors for late presentation in a cohort of HIV-infected patients in Dresden: positive serology for syphilis in MSM is a determinant for earlier HIV diagnosis. Infection. 2013;41(6):1145–55.CrossRefPubMed
4.
go back to reference Zoufaly A, an der Heiden M, Marcus U, Hoffmann C, Stellbrink H, Voss L, van Lunzen J, Hamouda O, G. ClinSurv Study. Late presentation for HIV diagnosis and care in Germany. HIV Med. 2012;13(3):172–81.CrossRefPubMed Zoufaly A, an der Heiden M, Marcus U, Hoffmann C, Stellbrink H, Voss L, van Lunzen J, Hamouda O, G. ClinSurv Study. Late presentation for HIV diagnosis and care in Germany. HIV Med. 2012;13(3):172–81.CrossRefPubMed
5.
go back to reference Ryom L, Boesecke C, Gisler V, Manzardo C, Rockstroh JK, Puoti M, Furrer H, Miro JM, Gatell JM, Pozniak A, Behrens G, Battegay M, Lundgren JD, E.G. Board. Essentials from the 2015 European AIDS Clinical Society (EACS) guidelines for the treatment of adult HIV-positive persons. HIV Med. 2015. Ryom L, Boesecke C, Gisler V, Manzardo C, Rockstroh JK, Puoti M, Furrer H, Miro JM, Gatell JM, Pozniak A, Behrens G, Battegay M, Lundgren JD, E.G. Board. Essentials from the 2015 European AIDS Clinical Society (EACS) guidelines for the treatment of adult HIV-positive persons. HIV Med. 2015.
6.
go back to reference Antinori A, Coenen T, Costagiola D, Dedes N, Ellefson M, Gatell J, Girardi E, Johnson M, Kirk O, Lundgren J, Mocroft A, D’Arminio Monforte A, Phillips A, Raben D, Rockstroh JK, Sabin C, Sonnerborg A, de Wolf F, G. European Late Presenter Consensus Working. Late presentation of HIV infection: a consensus definition. HIV Med. 2011;12(1):61–4.CrossRefPubMed Antinori A, Coenen T, Costagiola D, Dedes N, Ellefson M, Gatell J, Girardi E, Johnson M, Kirk O, Lundgren J, Mocroft A, D’Arminio Monforte A, Phillips A, Raben D, Rockstroh JK, Sabin C, Sonnerborg A, de Wolf F, G. European Late Presenter Consensus Working. Late presentation of HIV infection: a consensus definition. HIV Med. 2011;12(1):61–4.CrossRefPubMed
8.
go back to reference Smith CJ, Ryom L, Weber R, Morlat P, Pradier C, Reiss P, Kowalska JD, de Wit S, Law M, el Sadr W, Kirk O, Friis-Moller N, Monforte A, Phillips AN, Sabin CA, Lundgren JD, D.A.D.S. Group. Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): a multicohort collaboration. Lancet. 2014;384(9939):241–8.CrossRefPubMed Smith CJ, Ryom L, Weber R, Morlat P, Pradier C, Reiss P, Kowalska JD, de Wit S, Law M, el Sadr W, Kirk O, Friis-Moller N, Monforte A, Phillips AN, Sabin CA, Lundgren JD, D.A.D.S. Group. Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): a multicohort collaboration. Lancet. 2014;384(9939):241–8.CrossRefPubMed
9.
go back to reference MacCarthy S, Bangsberg DR, Fink G, Reich M, Gruskin S. Late presentation to HIV/AIDS testing, treatment or continued care: clarifying the use of CD4 evaluation in the consensus definition. HIV Med. 2014;15(3):130–4.CrossRefPubMedPubMedCentral MacCarthy S, Bangsberg DR, Fink G, Reich M, Gruskin S. Late presentation to HIV/AIDS testing, treatment or continued care: clarifying the use of CD4 evaluation in the consensus definition. HIV Med. 2014;15(3):130–4.CrossRefPubMedPubMedCentral
10.
go back to reference Mocroft A, Lundgren JD, Ross M, Law M, Reiss P, Kirk O, Smith C, Wentworth D, Neuhaus J, Fux CA, Moranne O, Morlat P, Johnson MA, Ryom L, D.A.D.s. group, C. Royal Free Hospital Clinic, I.s. group, S.s. group, E.s. group. Development and validation of a risk score for chronic kidney disease in HIV infection using prospective cohort data from the D:A:D study. PLoS Med. 2015;12(3):e1001809.CrossRefPubMedPubMedCentral Mocroft A, Lundgren JD, Ross M, Law M, Reiss P, Kirk O, Smith C, Wentworth D, Neuhaus J, Fux CA, Moranne O, Morlat P, Johnson MA, Ryom L, D.A.D.s. group, C. Royal Free Hospital Clinic, I.s. group, S.s. group, E.s. group. Development and validation of a risk score for chronic kidney disease in HIV infection using prospective cohort data from the D:A:D study. PLoS Med. 2015;12(3):e1001809.CrossRefPubMedPubMedCentral
11.
go back to reference O’Shea D, Ebrahim M, Egli A, Redmond D, McConkey S. Late presentation of HIV despite earlier opportunities for detection, experience from an Irish tertiary referral institution. Ir J Med Sci. 2013;182(3):389–94.CrossRefPubMed O’Shea D, Ebrahim M, Egli A, Redmond D, McConkey S. Late presentation of HIV despite earlier opportunities for detection, experience from an Irish tertiary referral institution. Ir J Med Sci. 2013;182(3):389–94.CrossRefPubMed
12.
go back to reference Agency HP. HIV in the United Kingdom: 2008 Report. London: Health Protection Agency. 2008. Agency HP. HIV in the United Kingdom: 2008 Report. London: Health Protection Agency. 2008.
13.
go back to reference Borghi V, Girardi E, Bellelli S, Angeletti C, Mussini C, Porter K, Esposito R. Late presenters in an HIV surveillance system in Italy during the period 1992–2006. J Acquir Immune Defic Syndr. 2008;49(3):282–6.CrossRefPubMed Borghi V, Girardi E, Bellelli S, Angeletti C, Mussini C, Porter K, Esposito R. Late presenters in an HIV surveillance system in Italy during the period 1992–2006. J Acquir Immune Defic Syndr. 2008;49(3):282–6.CrossRefPubMed
14.
go back to reference Sulis G, El Hamad I, Fabiani M, Rusconi S, Maggiolo F, Guaraldi G, Bozzi G, Bernardini C, Lichtner M, Stentarelli C, Carenzi L, Francisci D, Saracino A, Castelli F, HIV/Migrants Study Group. Clinical and epidemiological features of HIV/AIDS infection among migrants at first access to healthcare services as compared to Italian patients in Italy: a retrospective multicentre study, 2000–2010. Infection. 2014;42(5):859–67.CrossRefPubMed Sulis G, El Hamad I, Fabiani M, Rusconi S, Maggiolo F, Guaraldi G, Bozzi G, Bernardini C, Lichtner M, Stentarelli C, Carenzi L, Francisci D, Saracino A, Castelli F, HIV/Migrants Study Group. Clinical and epidemiological features of HIV/AIDS infection among migrants at first access to healthcare services as compared to Italian patients in Italy: a retrospective multicentre study, 2000–2010. Infection. 2014;42(5):859–67.CrossRefPubMed
Metadata
Title
High proportion of HIV late presenters at an academic tertiary care center in northern Germany confirms the results of several cohorts in Germany: time to put better HIV screening efforts on the national agenda?
Authors
Guido Schäfer
Benno Kreuels
Stefan Schmiedel
Sandra Hertling
Anja Hüfner
Olaf Degen
Jan van Lunzen
Julian Schulze zur Wiesch
Publication date
01-06-2016
Publisher
Springer Berlin Heidelberg
Published in
Infection / Issue 3/2016
Print ISSN: 0300-8126
Electronic ISSN: 1439-0973
DOI
https://doi.org/10.1007/s15010-016-0880-4

Other articles of this Issue 3/2016

Infection 3/2016 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.